(12) Patent Application Publication (10) Pub. No.: US 2017/0130247 A1 Dowen Et Al

(12) Patent Application Publication (10) Pub. No.: US 2017/0130247 A1 Dowen Et Al

US 2017O 130247A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2017/0130247 A1 DOWen et al. (43) Pub. Date: May 11, 2017 (54) COMPOSITIONS AND METHODS FOR Related U.S. Application Data ALTERING GENE EXPRESSION (60) Provisional application No. 62/234.770, filed on Sep. (71) Applicant: Whitehead Institute for Biomedical 30, 2015. Research, Cambridge, MA (US) Publication Classification (72) Inventors: Jill M. Dowen, Chapel Hill, NC (US); (51) Int. C. Zi Peng Fan, Waltham, MA (US); CI2N 15/90 (2006.01) Denes Hnisz. Cambridge, MA (US); (52) U.S. C. Tong Ihn Lee, Somerville, MA (US); CPC ........ CI2N 15/907 (2013.01); C12N 2800/80 Richard A. Young, Boston, MA (US) (2013.01) (21) Appl. No.: 15/282,905 (57) ABSTRACT Provided herein are improved compositions and methods for (22) Filed: Sep. 30, 2016 the directed control of gene expression. Patent Application Publication May 11, 2017. Sheet 1 of 43 US 2017/O130247 A1 Figare i i00,000 Chronosoines: {},{}{}{} {{E} opologicaily s Associating otains {{ Gene loops Naceosonies Patent Application Publication May 11, 2017. Sheet 2 of 43 US 2017/O130247 A1 Figure : S. Kic Enhanceti 4% Promoter 3% Polyconi S9, the Patent Application Publication May 11, 2017. Sheet 3 of 43 US 2017/O130247 A1 Figure Reads {-aight 4{{ } {{}{.{{}{} Unique PETs 9,442.89) PET peaks & & ... & & & ...& 8...&... & f68.88: } interactions annig PET peaks High-coficience: iteraction agg FE peaks (empirical FER<-0.0i, 3. --- "C" ·&&.8.xxx................ oxoi.8°8'''88's'ss's48&S SMC “tookook os---to do OSN &: : or Super-enhance :::: 88: Patent Application Publication May 11, 2017. Sheet 5 of 43 US 2017/O130247 A1 Figar: 2 Hi-C interaction frequencies opoiogicaiy Associating 8) nat: High-confidence iteraction * Genes Patent Application Publication May 11, 2017. Sheet 6 of 43 US 2017/O130247 A1 Figure 2 3. 8 o 3. & 8. 40 s 3 & O is: w88:3 (C. 2% 88% beyond within TAS A38 Patent Application Publication May 11, 2017. Sheet 7 of 43 US 2017/O130247 A1 Figare 2 3. S E. High-confidence iteraction &: '8; 8.3388& 8 £3 xxiiciaty 8:33rtiary Patent Application Publication May 11, 2017. Sheet 8 of 43 US 2017/O130247 A1 Figare 3 gx38xicaisy &883::::::g. 88ai & s ; : . i ii. - - - - - - - - - - - - - - - - -& xxx s'. 8.8 3 s : & {{xxixg:kaiy &ssocia: 3883i: &::::::: 8: ki::ity (388 Patent Application Publication May 11, 2017 Sheet 9 of 43 US 2017/O130247 A1 38 v. 2: 43 Patent Application Publication May 11, 2017. Sheet 10 of 43 US 2017/0130247 A1 : 8 8. 8. : 33:888sy d 38.3888; Patent Application Publication May 11, 2017 Sheet 11 of 43 US 2017/O130247 A1 Patent Application Publication May 11, 2017. Sheet 12 of 43 US 2017/0130247 A1 Figure 4 A. 3888-8::::3::ce. Eg: . Patent Application Publication May 11, 2017. Sheet 13 of 43 US 2017/0130247 A1 Figure 4 83 & &:::::::::::::::::::::::::::::::::: 3:33 s 8-8-- 88:88. Patent Application Publication May 11, 2017 Sheet 14 of 43 US 2017/O130247 A1 Figare 4 8. f 3:38:8 8 ::::::::: ;----~--~~~~~~*~*~~~~~~~~~~~~****~~~~~~~~~~*** Patent Application Publication May 11, 2017. Sheet 15 of 43 US 2017/0130247 A1 Figure 4 M 8:38-:388:88): 38::::::::: d Patent Application Publication May 11, 2017. Sheet 16 of 43 US 2017/0130247 A1 Figure 4 &-88::::::: 3:3: Patent Application Publication May 11, 2017. Sheet 17 of 43 US 2017/0130247 A1 Figure 5 A. *:::::::::::::::::::::: » x&g::::::::x: 8x8:3388:8: i: 888 {3888 Patent Application Publication May 11, 2017. Sheet 18 of 43 US 2017/0130247 A1 Figare 5 ---------------------------------- 88:3: 8:3 Patent Application Publication May 11, 2017. Sheet 19 of 43 US 2017/0130247 A1 Figure 5 3. r: stews p boundary bo::ciary Patent Application Publication May 11, 2017. Sheet 20 of 43 US 2017/0130247 A1 Figares $388:383 3:38 Y s 3. 88: s - Patent Application Publication May 11, 2017. Sheet 21 of 43 US 2017/0130247 A1 Figare 5 :: S8.s: 8s: Patent Application Publication May 11, 2017. Sheet 22 of 43 US 2017/0130247 A1 i Patent Application Publication May 11, 2017 Sheet 23 of 43 US 2017/O130247 A1 Patent Application Publication May 11, 2017. Sheet 25 of 43 US 2017/O130247 A1 Figtre 7 (Figare Si No.ººººººººººººººº! 7% Enhancer Patent Application Publication May 11, 2017. Sheet 26 of 43 US 2017/0130247 A1 Figure 7 Figare Si Patent Application Publication May 11, 2017. Sheet 27 of 43 US 2017/0130247 A1 Figarei (Figure Si) g 38:38::::::::::: P a. 838-3. a m . s4 &::*-8 & oc or - 2 2 88-8 - K r 88. K3 & 38.x: Rep; on Seif-tigation E. count 3'er kb bins (r.p.k.a. } x-, s 8 8. 8: Patent Application Publication May 11, 2017. Sheet 28 of 43 US 2017/0130247 A1 Figre 7 (Figure Si Non-chrei PE {Chineric PET a: - 3338. : & 38. 38 33. :8 Geronic 8ian Genomic span it of PETs per interaction Patent Application Publication May 11, 2017. Sheet 29 of 43 US 2017/0130247 A1 Figure 7 (Figure S. G. interactions High-confidence interactions {erapiricai FOR <30.8, 3:Es) 82% 8% - 39% ter-chronixsotia 33-chroniososia tier-chronosoina intra-chioiosonkai Saiitiation of the Sw: , Ch;A-PET Library Fraction of PETs Reiative to Current ataset Size Patent Application Publication May 11, 2017. Sheet 30 of 43 US 2017/0130247 A1 Figare 8 (iigstre S2) 3::::::::::::::: &x:3:33:33:3:38 ix::c:gic:y 8888ciatig :::::::::::: :::::::::: Patent Application Publication May 11, 2017. Sheet 31 of 43 US 2017/0130247 A1 Figure 8 Figtre S2) 33:::::: *:::::::38: $23888; 8: 83. 2333} :::::: 3:3: & 8:8::::::::::8 88:38-3:8:::::::::: 3i. 23:3: Patent Application Publication May 11, 2017. Sheet 32 of 43 US 2017/0130247 A1 Figs re 9 (Figtse S3} seases 8:x: 3:33:8:33:::::::: Six:8: & ...wik.... ...wikowow. & k sax Patent Application Publication May 11, 2017. Sheet 33 of 43 US 2017/0130247 A1 Figare 9 (Figure S3) & 838:33:3:3: M 8:88-8383:38:338:3 &: kx sixko www.s. S3888-8:33:3: Ex:3: i:88s &:s:x::::::::::::::::::::: to so &:83-8:33:30:8: 3888... : Patent Application Publication May 11, 2017. Sheet 34 of 43 US 2017/0130247 A1 Figure 9 (Figure S3 mem &:g::::::::::::::88: 3:3:38 Patent Application Publication May 11, 2017. Sheet 35 of 43 US 2017/0130247 A1 Figare 9 (Figure S3 ::::::::::::::::::y;&&8:::::::::::33:8: &::::::::::::::::ce: 3:38: Patent Application Publication May 11, 2017. Sheet 36 of 43 US 2017/0130247 A1 Figure 8 (Figure S4 8:88-8:38& $3838 3C-888&gatx 3:23:8388 : {38: ra sig3:8:8; 88-388-388 33 Patent Application Publication May 11, 2017. Sheet 37 of 43 US 2017/0130247 A1 Figure 8 (Figure S4 win $:383-8:38:3: 3883: -j-i-m-i-. - s 38-8errogated 8:3:33:38 3.33. :::::::S:8: 3x38:38 Patent Application Publication May 11, 2017. Sheet 38 of 43 US 2017/0130247 A1 Figarei (Figure S4 wix type ESC 3C 3 trix-388-38. sSS s *::::::::::::::y :::::::::::: k:gixxist: 88:88: ::::::::: 3:x: Patent Application Publication May 11, 2017. Sheet 39 of 43 US 2017/0130247 A1 Figare ii (Figre S5) 3::::::::::::::::::y 8888c:::::::::33::::::: t 38 ---........................ Sssssssssssssss ii; Patent Application Publication May 11, 2017. Sheet 40 of 43 US 2017/0130247 A1 Figare (Fig are S5) 3:388x338; 8.388x333i: 38883: hoto-8: $8ycory: s38::::::: - X::::::::::: 3:8338c:38;33 8:::::::::::::::::::38:8w Patent Application Publication May 11, 2017. Sheet 41 of 43 US 2017/0130247 A1 Figure ii (Figure S5) x:3:38:8: Patent Application Publication May 11, 2017. Sheet 42 of 43 US 2017/0130247 A1 Figtre i (Figare S5) ::::::::::::::::::y 8$88:a::g .3388: $3::::::::: 33;x:::::::::::::: *$88:::::::::::::38:8 ::::::::::::8& Patent Application Publication & $$$84 US 2017/O 130247 A1 May 11, 2017 COMPOSITIONS AND METHODS FOR 2012: Filippova et al., 2014; Gibcus and Dekker, 2013; ALTERING GENE EXPRESSION Naumova et al., 2013: Nora et al., 2012). 0009 TADs, also known as topological domains, are CROSS-REFERENCE TO RELATED defined by DNA-DNA interaction frequencies, and their APPLICATION(S) boundaries are regions across which relatively few DNA DNA interactions occur (Dixon et al., 2012: Nora et al., 0001. This application claims the benefit of U.S. Provi 2012). TADs average 0.8 Mb, contain approximately seven sional Application No. 62/234,770, filed Sep. 30, 2015. The protein-coding genes, and have boundaries that are shared entire teachings of the above application is incorporated by the different cell types of an organism (Dixon et al., 2012: herein by reference. Smallwood and Ren, 2013). The expression of genes within aTAD is somewhat correlated, and thus some TADs tend to GOVERNMENT SUPPORT have active genes and others tend to have repressed genes 0002 This invention was made with government support (Cavalli and Misteli, 2013; Gibcus and Dekker, 2013: Nora under Grant Number HG002668 awarded by the National et al., 2012). Institutes of Health. The government has certain rights in the 0010 Gene loops and other structures within TADs are invention. thought to reflect the activities of transcription factors (TFs), cohesin, and CTCF (Baranello et al., 2014: Gorkin et al., FIELD OF THE INVENTION 2014; Phillips-Cremins et al., 2013: Seitan et al., 2013; Zuin et al., 2014). The structures within TADs include cohesin 0003. The present invention generally relates to methods associated enhancer-promoter loops that are produced when of selectively altering gene expression within, for example, enhancer-bound TFs bind cofactors such as Mediator that, in insulated neighborhoods formed by the looping of two turn, bind RNA polymerase II at promoter sites (Lee and CTCF interaction sites occupied by cohesion.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    122 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us